Nabriva Therapeutics plc

Delisted

CIK 1641640fmd_1A16DDH3GWEAVZF7XEHNY7S1T0Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2014 to Jun 30, 2023, 35 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).